• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Secretary Rubio scheduled to face former colleagues on Venezuela policy

by January 21, 2026
written by January 21, 2026

Secretary of State Marco Rubio is set to publicly testify on the Trump administration’s actions in Venezuela in the Senate next week.

Returning to his old stomping grounds in the Senate has become fairly routine for Rubio over the last few months, particularly as lawmakers have demanded more transparency over the administration’s actions in Venezuela and the Caribbean.

And once again, Rubio will appear on the Hill when the Senate returns from recess next week, sources confirmed to Fox News Digital. He is scheduled to appear before the Senate Foreign Relations Committee on Jan. 28 at 10 a.m.

The hearing before the panel comes after Rubio acted as a key figure to convince a pair of holdouts — Sens. Todd Young, R-Ind., and Josh Hawley, R-Mo. — to flip their votes and kill an attempt by Senate Democrats to rein in President Donald Trump’s war authorities last week.

Their primary concerns were that the administration would put boots on the ground in the region, and that Congress should have a say if that were the case.

Through assurances, guarantees and an agreement to publicly testify on the matter, Rubio appeared to win them over.

Young said at the time that he had to ‘accept that this was a communications exercise,’ but noted that it was a moment used to ‘shine a bright light on Congress’ shortcomings as it relates to war powers in recent history.’

Rubio also wrote to Senate Foreign Relations Chair James Risch, R-Idaho, ahead of the vote last week to spell out that the administration would clue in Congress should any future military action take place in the region.

He then re-upped that same message to Young, where he said that should Trump ‘determine that he intends to introduce U.S. Armed Forces into hostilities in major military operations in Venezuela, he would seek congressional authorization in advance (circumstances permitting).’

Still, despite these guarantees to Republicans, Sen. Tim Kaine, D-Va., who sits on the committee, plans to continue his quest to corral Trump’s war authorities.

Kaine said before lawmakers left Washington that he planned to ‘file every one I can to challenge emergencies, to challenge unlawful wars, to seek human rights reports, arms transfers if they’re wrong.’

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Democrats dodge questions as House GOP prepares contempt votes against the Clintons
next post
Trump doubles down on Greenland push as polls show little public support

related articles

DHS scorches Pritzker’s ‘sanctuary’ state after child rapist...

May 1, 2026

Socialist mayor’s blunt 1-word message to fleeing millionaires...

May 1, 2026

DC police captain cites bodycam footage of officers...

May 1, 2026

Amazon explores ‘The Apprentice’ reboot with Trump Jr...

May 1, 2026

MN governor race to replace Walz sees major...

May 1, 2026

Trump’s apocalyptic Iran warning raises stakes for sweeping...

April 7, 2026

Graham eyes ‘down payment’ on Trump-backed SAVE Act...

April 7, 2026

Democrat whose parents fled Iran moves to oust...

April 7, 2026

Midterm alarm bells: Democrats face steep favorability deficit...

April 7, 2026

American journalist kidnapped in Iraq is set free,...

April 7, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Here’s why Futu Holdings stock is on the verge of a rebound this week

    March 11, 2026
  • Israel continues to strike Gaza, killing dozens of Palestinians days after ceasefire ends

    March 20, 2025
  • Who will Trump pick next for attorney general after Gaetz’s withdrawal?

    November 21, 2024
  • Merck creates separate oncology arm ahead of Keytruda patent loss

    February 23, 2026
  • Mike Johnson asks embattled House Republican Tony Gonzales to drop re-election bid

    March 5, 2026

Popular Posts

  • 1

    District judges’ orders blocking Trump agenda face hearing in top Senate committee

    April 2, 2025
  • 2

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 3

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 4

    CoreWeave eyes $1.5B bond raise to ease debt load following lacklustre IPO: report

    May 9, 2025
  • 5

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024

Categories

  • Economy (829)
  • Editor's Pick (8,507)
  • Investing (2,338)
  • Stock (1,028)

Latest Posts

  • White House fires court-appointed US attorney on day he is sworn in

    February 13, 2026
  • Former Virginia governor challenges Spanberger to debate her redistricting flip-flop

    April 1, 2026
  • Trump dismisses Musk’s political ambitions as ‘ridiculous’ in sharp rebuke

    July 7, 2025

Recent Posts

  • Where Vance and Walz favorability ratings stand 60 days to Election Day

    September 5, 2024
  • Analysts see these US chemical stocks gaining as Middle East conflict deepens

    March 12, 2026
  • ‘Held accountable’: Sen. Rand Paul again vows to issue a criminal referral for Fauci

    July 14, 2025

Editor’s Pick

  • Trump learns a lesson grounded in faith, how best to stand tough on trade with China

    August 24, 2025
  • Energy expert weighs in on 23 state attorneys general suing EPA over new methane emissions fee

    January 17, 2025
  • Trump tariff spike fuels new House bill to lock China out of US government tech

    April 10, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock